ORIGINAL ARTICLE
REVISTA DE LA FACULTAD DE MEDICINA HUMANA 2019 - Universidad Ricardo PalmaDOI 10.25176/RFMH.v20i1.2543
SEVERITY PROGNOSTIC FACTORS IN PATIENTS WITH ACUTE PANCREATITIS IN HOSPITAL NACIONAL SERGIO E. BERNALES
FACTORES PRONÓSTICOS DE SEVERIDAD EN PANCREATITIS AGUDA EN UN HOSPITAL NACIONAL SERGIO E. BERNALES
Hellen Jamanca Milian1,a,
Luis Cano Cardenas2,b
1 National Hospital Sergio E. Bernales. Lima, Peru.
2 National Hospital Dos de Mayo. Lima, Peru
a Surgeon
b Internist
ABSTRACT
Objective: To determine the prognostic factors of severity in patients with acute pancreatitis (AP) at the Hospital Nacional Sergio E. Bernales during the period June 2016 to June 2018. Methods: Study of cases and controls, being the cases patients with AP moderately severe or severe and controls those of mild AP. The medical records were reviewed to apply the APACHE-II score. Chi-square was used and the ORs were obtained with their respective 95% CI. SPSS 25 program was used. Results: 162 medical records were reviewed. 54 (33.3%) patients developed AP moderately severe or severe and 108 (66.7%) had mild AP. Of the patients with AP moderately severe or severe, 55.6% were men; while in mild AP the female sex was predominant with 91.7%. The majority were of biliary origin (83.3%). There was a predominance of mild AP. AP moderately severe or severe was associated with being over 60 years old (OR: 3.10; 95% CI: 1.26-7.65; p= 0.011), presenting pleural effusion (OR: 7.78 95% CI: 5.745-54.418 ; p <0.001), hematocrit>40% (OR: 4.17; 95% CI: 2.07-8.39; p <0.001) and APACHE score ≥8 (OR: 7.88; 95% CI: 3.77-16.45; p<0.001). Conclusions: The factors associated with the severity of pancreatitis were age, presenting pleural effusion, hematocrit> 40% and APACHE score ≥8.
Keywords: Pancreatitis, APACHE, Prognosis (MeSH MEDLINE)
RESUMEN
Objetivo: Determinar los factores pronósticos de severidad en pacientes con pancreatitis aguda (PA) en el Hospital Nacional Sergio E. Bernales durante el periodo junio 2016 a junio 2018. Métodos: Estudio de casos y controles, siendo los casos los pacientes con pancreatitis moderada o severa y los controles los de pancreatitis leve. Los datos para las variables evaluadas fueron obtenidos a partir de la revisión de Historias Clínicas. Se usó chi-cuadrado para evaluar la asociación y se hallaron los OR con sus respectivos IC 95%. Se utilizó programa SPSS 25. Resultados: Se revisaron 162 historias clínicas de los cuales 54 (33,3%) pacientes desarrollaron PA moderadamente severa (PAMS) o severa (PAS) y 108 (66.7%) cursaron con PA leve (PAL). De las PAMS y PAS 55,6% fueron hombres; mientras que en las PA leves el sexo femenino fue el predominante con un 91,7 %. La mayoría fue de origen biliar con un 83,3%. Los factores asociados a PAMS/PAS incluyeron tener más de 60 años (OR: 3.10; IC 95%: 1,26-7,65; p= 0.011), presentar derrame pleural (OR: 7,78 IC 95%: 5,745-54,418; p<0.001), hematocrito >40% (OR: 4,17; IC 95%: 2.07-8.39; valor p: <0.001) y puntuación APACHE ≥8 (OR: 7,88; IC 95%: 3.77-16.45; p<0,001). Conclusiones: Los factores asociados a severidad de la pancreatitis fueron la edad, presentar derrame pleural, hematocrito >40% y puntuación APACHE ≥8.
Palabras Clave: Pancreatitis, APACHE, Pronóstico (DeCS BIREME)
INTRODUCTION
Acute pancreatitis (AP) is one of the most common gastrointestinal disorders that require hospitalization. Most of them are mild and self-limited, 30% are moderately severe and 10% are severe. Organ failure (OF) is the main gravity determinant and cause of early death. Overall mortality is 3-6% and increases to 30% in severe AP. Secondary infections, including infected ANP and sepsis, are responsible of more deaths in the last years.(4).
Acute pancreatitis worldwide incidence has increased steadily, and ranges from 4.9 to 73.4 cases for each 100 000 inhabitants worldwide. Regarding Latin America, there was reported an incidence of 15.9 cases for each 100 000 inhabitants in Brazil, in 2006; a 3% incidence in Mexico in 2001 and an incidence of 28 cases for each 100 000 inhabitants, according to the statistics from Ministry for Health of Peru in 2009. Biliary etiology is primarily responsible for almost 70% of every case registered.(5).
In a 2013 revision of the Atlanta classification, pancreatitis is categorized in mild, if there are neither organ failure nor local or systemic complications; moderate, if there is a transitory organ failure (lower than 48 hours) or systemic or local complications with no organ failure; and severe, if there is a persistent organ failure, which could be unique or multiple.(6). Although patients with severe AP represent a small proportion of patient with AP, these show a major morbidity and mortality, require special management and access to an Intensive Care Unit(7). Being able to predict this severity may help us identify patients with increased risk of morbidity and mortality(5).
Severity can be predicted using clinical, laboratory and radiological parameters, severity indices and serum markers. Many of them can be obtained at the moment or within 48 hours. Nonetheless, the best predictor must be fast, reproducible, minimally invasive and accurate, especially for predicting patients with increased risk of death.(8).
There has been a development of many scoring systems for the purpose of predicting the course of acute pancreatitis. For example, Ranson, APACHE II, BISAP, etc. which reach acceptable degrees of sensibility and specificity, but take more than 24 hours to be completed.
The main utility of prognostic systems are: to detect severe cases early, to select patients to assign treatment, to refer patients to specialized centers, to compare patients between different series and to recruit patients for new treatments.(12).
Consequently, the need and importance to early and properly know and detect the severity prognostic factors in patients with AP will allow us carry an early and correct management in terms of these kind of patients, avoiding a great impact in their morbidity and mortality.
The main objective of this study is to determine severity prognostic factors in patients with acute pancreatitis (AP) in the National Hospital Sergio E. Bernales.
METHODS
Retrospective, observational, analytical, quantitative, case-control study.
We worked with patients diagnosed with acute pancreatitis in the gastroenterology service of the National Hospital Sergio E. Bernales from June 2016 until June 2018, who were classified in 2 study groups according to disease severity: patients with moderately severe and severe acute pancreatitis (cases); patients with mild acute pancreatitis (controls).
Data collection technique used was documentation, due to the use of secondary sources. That is to say, we reviewed medical records of every patient diagnosed with acute pancreatitis.
A data collection sheet was used as an instrument, which recorded the following information: epidemiological data (age, sex); clinical data (etiology, nutritional status, and pleural effusion); laboratory data (glucose and hematocrit level) and clinical-laboratory data (APACHE-II).
A database was created in the statistical program SPSS version 25, where was carried out a quality control of registers through consistence, compilation and re-categorization, providing a database without inaccurate or missing data and the ability to correct inaccuracies in data input and collection. We found OR with their correspondents confidence intervals at 95%.
RESULTS
We reviewed 162 medical records with a diagnostic of acute pancreatitis, the cases were 54 (33.3%) patients who developed moderately severe AP (MSAP) or severe AP (SAP) and the controls, 108 (66.7%) presented mild AP. Clinical features can be observed in table 1.
Table 1. Clinical features of study population
Regarding table 1 about clinical features of 162 patients, we obtained that 30 (55.6%) of MSAP and SAP were male; while female prevailed in terms of mild AP with 99 (91.7%) patients. Regarding etiology displayed on table 2, we found that 135 patients (83.3%) were of biliary etiology, 19 (11.7%) of alcoholic etiology and 8 patients (4.9%) presented other causes. Concerning MSAP and SAP, 35 (64.8%) were of biliary etiology. Amongst mild AP, it prevailed the same etiology.
Table 2. Bivariate analysis of severity prognostic factors of acute pancreatitis
In table 2 the bivariate analysis shows that patients over 60 were 3.1 times more likely to develop MSAP and SAP, in contrast with patients under this age (OR: 3.10; CI 95%: 1.26-7.65; p value: 0.011).
Patients with overweight and obesity (BMI ≥25 kg/m2) are 2.08 times more likely to develop MSAP and SAP in comparison to those who got a BMI <25 (OR: 2.08; CI 95%:1.02-4.21; valor p: 0.040).
Regarding patients who developed MSAP and SAP, 74.1% of them showed pleural effusion, with an OR of 7.78 and a p value <0.001. When it comes to patients with hematocrit >40%, they were 4.17 times more likely to develop MSAP and SAP, in contrast to those who got hematocrit <40% (OR: 4.17; CI 95%: 2.07-8.39; p value: <0.001).
In the matter of Apache score of ≥8 marks, we noted that patients were 7.88 times more likely to show disease severity in comparison with those who got a score of <8 (OR: 7.88; CI 95%: 3.77-16.45; p value:<0,001). The variable with which there was not statistically non-significant association was glycaemia’s ≥200 mg/dl.
Table 3. Multivariate analysis of severity prognostic factors of acute pancreatitis
For the multivariate analysis displayed on table 3, we carried out a binary logistic regression analysis with the results obtained in the bivariate analysis, considering statistically significant variables.
The severity prognostic factors in patients with acute pancreatitis during the period from June 2016 until June 2018 were BMI ≥25 kg/m2 (p=0.001), pleural effusion (p=<0.001), hematocrit (p=<0.001) and apache ≥8 points (p=<0.001), all these factors with statistically significant values.
DISCUSSION
In this research, regarding epidemiological characteristics in patients with acute pancreatitis, we found that 33.3% of patients developed moderately severe acute pancreatitis (MSAP) or severe (SAP). Ocampo et al found similar studies with mild AP of 83.6% and severe AP of 16,4%(2) in 2015.; Likewise in 2012, Enrique Madaria mentions in his study that 39.1% developed severe AP(29). These numbers cannot be compared with Molina’s research in 2013, which concluded that 82.4% corresponded to severe acute pancreatitis.(30).
Regarding the relationship between severity and sex, Molina obtained that female (53%) prevailed in terms of acute pancreatitis, in general. Nonetheless, concerning severe acute pancreatitis, it was male sex (53.6%)(30) who prevailed. In our research, we found that 55.6% of MSAP and SAP were from male; while female sex prevailed regarding mild AP with 91.7%.
In relation to the etiology of acute pancreatitis, 83.3% were of biliary origin, 11.7% alcoholic and 4.9% had other causes. Gompertz et al noted that the most frequent etiology of AP was biliary, reaching 80-100% of causes in some hospitals in Ecuador and Peru, and 45-60% in Chile, Argentina and Brazil(1). Alcohol consumption was an etiologic factor in 10-20%, with a similar number of cases considered idiopathic(1); Ocampo et al name a similar result with 88.2% of biliary etiology as the main cause of acute pancreatitis(2).
Concerning the relationship between disease severity and etiology, we obtained that 64.8% of MSAP and SAP were of biliary etiology. Amongst mild AP, it prevailed the same etiology. These findings agree with Molina, who found that the main cause of acute pancreatitis, in both mild and severe, was a biliary process with a proportion over 80%.(30)
In a 2011 research carried out by Chavarría et al, at National Hospital Cayetano Heredia, they found that APACHE II score with a cut-off point of 8 presented 9.02 times more likelihood to show disease severity with a p value under 0.01, in contrast to the group who showed the mild form.(9). This agrees with our study’s findings, where we noted that an apache of ≥8 points apache represents 7.88 times the likelihood to develop severe acute pancreatitis, in comparison with those who got an apache of <8 points (OR: 7.88; CI 95%: 3.77-16.45; p value:<0.001). Jin et al, in 2017, proved that an APACHE II score of ≥ 8 was a risk factor for developing moderately severe AP or severe AP with an OR of 29.096 and a p value of <0.00133. Furthermore, we carried out the multivariate analysis of statistically significant variables. There we could note related results to our research with an OR of 25.064 and a p value of <0.001. Thus, proving to be a useful predictor for discerning between both groups in our environment.
Pacheco et al, in 2009, reported that acute pancreatitis severity was influenced by age (OR: 1.02; IC 95%: 1.01–1.04, p value: 0.001)(15). Our research does not agree, however, with the previous result. We carried out a multivariate analysis to every bivariate analysis’ statistically significant variable, but we did not found statistical significance in age >60 years old as a severity prognostic factor (OR: 0.735, CI 95%: 0.202-2.679; p value: 0.641). In a research by Roulin et al in 2018, we found similar results. There was no difference regarding clinical and radiological severity of acute pancreatitis between elderly and young people (p value: 0.210).(19).
In our research, a BMI ≥25 kg/m2, was statistically significant (OR: 2.08; CI 95%:1.02-4.21; p value: 0.040). Many published studies support this argument, since obesity is one of the most significant severity negative prognostic factors and increases both risk of local and systemic complications. According to Fei Y et al in 2017, univariate analysis confirmed that BMI Is significantly related to severity of AP with an OR of 0.917; IC 95%: 0.682-1.733, valor p: 0.011(20). Likewise, in a study published at National Hospital Daniel Alcides Carrión by Guzmán in 2012, 14 out of 16 patients with severe pancreatitis got a BMI > 25. (p = 0.03; OR = 4.39)(25). The relationship between obesity and development of severe acute pancreatitis is due to the fact that obese patients have a chronic proinflammatory state, which may predispose them to a major inflammatory response if they develop acute pancreatitis. The hypothesis that supports this evidence comes from two studies that show an increase in both protein C and proinflammatory cytokines levels (IL-1b, IL-6 e IL8) in obese patients with acute pancreatitis in comparison with non-obese patients.(25)
Regarding blood glucose level, we did not found any statistical significance in our study (OR: 2.50; CI95%: 0.95-6.58; p value: 0.058), even though a study by Speranskaya in 2015 reports that blood glucose >200 after being admitted to the hospital is related with severity degree of pancreatitis (p < 0.001).(21). More studies are need in order to reaffirm these findings and to observe if a better glycaemia control while being admitted to the hospital influences in the hospital evolution of pancreatitis.
Hematocrit has been described in a number of studies as a possible severity marker in acute pancreatitis. Pathophysiologically, in severe cases it exists a redistribution of intravascular fluid towards a third space as a consequence of inflammatory process due to the initiation of inflammatory cascade, which joins a local process after an increase of pancreatic enzymes’ release. Thus, detection of this reduction in the intravascular volume could be related to disease severity. Chavarría et al (2001) state in their research that hematocrit average value in the group labeled as mild was 38.40%, whereas in the group of severe patients this average was 39.78% with p value: 0.182. Thus, it was a non-significant difference(9). However, in our study we obtained that patients who got hematocrit >40% were 4.17 times more likely to develop MSAP and SAP, unlike those who got hematocrit <40% (OR: 4.17; CI 95%: 2.07-8.39; p value: <0.001). Likewise, Sánchez in 2015 proved hematocrit to be a great predictor of acute pancreatitis severity with p value of 0.012.(34).
Presence of pleural effusion, an easy-to-prove mark, has been reported as a proper prognostic factor in various scientific papers. Nevertheless, in these papers presence of pleural effusion was researched through different radiological methods and within heterogeneous population with different etiologies in their pancreatitis. Also, in those papers, there is no comparison between predictive accuracy of presence of pleural effusion and prognostic systems of traditional multi-criteria. In our study, we obtained the following as a result of bivariate analysis: OR of 7.78 with a CI 95% between 3.70-16.35 y and p value of <0.001. This result is similar to the study published by Ocampo et al (2008), where evaluated pleural effusion through echography presented higher values of predictive accuracy in predicting systemic complications (OR: 6.3 CI95%: 2.85-14)(23). Further, León C. (2015) found in his research work that 100% of patients with severe pancreatitis presented pleural effusion(35).
CONCLUSION
In our study we established that pleural effusion is more frequent in patients with severe acute pancreatitis and together with the APACHE scale they were significantly associated, being the best predictors of disease severity.
Acute pancreatitis (AP) is one of the most common gastrointestinal disorders that require hospitalization. Most of them are mild and self-limited, 30% are moderately severe and 10% are severe. Organ failure (OF) is the main gravity determinant and cause of early death. Overall mortality is 3-6% and increases to 30% in severe AP. Secondary infections, including infected ANP and sepsis, are responsible of more deaths in the last years.(4).
Acute pancreatitis worldwide incidence has increased steadily, and ranges from 4.9 to 73.4 cases for each 100 000 inhabitants worldwide. Regarding Latin America, there was reported an incidence of 15.9 cases for each 100 000 inhabitants in Brazil, in 2006; a 3% incidence in Mexico in 2001 and an incidence of 28 cases for each 100 000 inhabitants, according to the statistics from Ministry for Health of Peru in 2009. Biliary etiology is primarily responsible for almost 70% of every case registered.(5).
In a 2013 revision of the Atlanta classification, pancreatitis is categorized in mild, if there are neither organ failure nor local or systemic complications; moderate, if there is a transitory organ failure (lower than 48 hours) or systemic or local complications with no organ failure; and severe, if there is a persistent organ failure, which could be unique or multiple.(6). Although patients with severe AP represent a small proportion of patient with AP, these show a major morbidity and mortality, require special management and access to an Intensive Care Unit(7). Being able to predict this severity may help us identify patients with increased risk of morbidity and mortality(5).
Severity can be predicted using clinical, laboratory and radiological parameters, severity indices and serum markers. Many of them can be obtained at the moment or within 48 hours. Nonetheless, the best predictor must be fast, reproducible, minimally invasive and accurate, especially for predicting patients with increased risk of death.(8).
There has been a development of many scoring systems for the purpose of predicting the course of acute pancreatitis. For example, Ranson, APACHE II, BISAP, etc. which reach acceptable degrees of sensibility and specificity, but take more than 24 hours to be completed.
The main utility of prognostic systems are: to detect severe cases early, to select patients to assign treatment, to refer patients to specialized centers, to compare patients between different series and to recruit patients for new treatments.(12).
Consequently, the need and importance to early and properly know and detect the severity prognostic factors in patients with AP will allow us carry an early and correct management in terms of these kind of patients, avoiding a great impact in their morbidity and mortality.
The main objective of this study is to determine severity prognostic factors in patients with acute pancreatitis (AP) in the National Hospital Sergio E. Bernales.
METHODS
Retrospective, observational, analytical, quantitative, case-control study.
We worked with patients diagnosed with acute pancreatitis in the gastroenterology service of the National Hospital Sergio E. Bernales from June 2016 until June 2018, who were classified in 2 study groups according to disease severity: patients with moderately severe and severe acute pancreatitis (cases); patients with mild acute pancreatitis (controls).
Data collection technique used was documentation, due to the use of secondary sources. That is to say, we reviewed medical records of every patient diagnosed with acute pancreatitis.
A data collection sheet was used as an instrument, which recorded the following information: epidemiological data (age, sex); clinical data (etiology, nutritional status, and pleural effusion); laboratory data (glucose and hematocrit level) and clinical-laboratory data (APACHE-II).
A database was created in the statistical program SPSS version 25, where was carried out a quality control of registers through consistence, compilation and re-categorization, providing a database without inaccurate or missing data and the ability to correct inaccuracies in data input and collection. We found OR with their correspondents confidence intervals at 95%.
RESULTS
We reviewed 162 medical records with a diagnostic of acute pancreatitis, the cases were 54 (33.3%) patients who developed moderately severe AP (MSAP) or severe AP (SAP) and the controls, 108 (66.7%) presented mild AP. Clinical features can be observed in table 1.
| Pancreatitis severity | Total | ||
| MSAP and SAP | Mild AP | ||
| Sex | |||
| Female | 24 (44,4%) | 99 (91,7%) | 123 (75,9%) |
| Male | 30 (55,6%) | 9 (8,3%) | 39 (24,1%) |
| Etiology | |||
| Biliary | 35 (64,8%) | 100 (92,6%) | 135 (83,3%) |
| Alcoholic | 17 (31,5%) | 2 (1,9%) | 19 (11,7%) |
| Other causes | 2 (3,7%) | 6 (5,6%) | 8 (4,9%) |
Regarding table 1 about clinical features of 162 patients, we obtained that 30 (55.6%) of MSAP and SAP were male; while female prevailed in terms of mild AP with 99 (91.7%) patients. Regarding etiology displayed on table 2, we found that 135 patients (83.3%) were of biliary etiology, 19 (11.7%) of alcoholic etiology and 8 patients (4.9%) presented other causes. Concerning MSAP and SAP, 35 (64.8%) were of biliary etiology. Amongst mild AP, it prevailed the same etiology.
| Severity of pancreatitis | OR (CI 95%)) | P value | ||
| MSAP and SAP | Mild AP | |||
| Age | ||||
| ≥60 años | 13 (24,1%) | 10 (9,3%) | 3,10 (1,26 – 7,65) | 0,011 |
| <60 años | 41 (75,9%) | 98 (90,7%) | ||
| BMI | ||||
| ≥25 kg/m2 | 39 (72,2%) | 60 (55,6%) | 2,08 (1,02 – 4,21) | 0,040 |
| <25 kg/m2 | 15 (27,8%) | 48 (44,4%) | ||
| Glycaemia | ||||
| ≥200 mg/dl | 10 (18,5%) | 9 (8,3%) | 2,50 (0,95 – 6,58) | 0,058 |
| <200 mg/dl | 44 (81,5%) | 99 (91,7%) | ||
| Pleural effusion | ||||
| Yes | 40 (74,1%) | 29 (26,9%) | 7,78 (3,70 – 16,35) | *0,001 |
| No | 14 (25,9%) | 79 (73,1%) | ||
| Hematocrit | ||||
| ≥40% | 37 (68,5%) | 37 (34,3%) | 4,17 (2,07 – 8,39) | *0,001 |
| <40% | 17 (31,5%) | 71 (65,7%) | ||
| APACHE score | ||||
| ≥8 points | 38 (70,4%) | 25 (23,1%) | 7,88 (3,77 – 16,45) | *0,001 |
| <8 points | 16 (29,6%) | 83 (76,9%) | ||
In table 2 the bivariate analysis shows that patients over 60 were 3.1 times more likely to develop MSAP and SAP, in contrast with patients under this age (OR: 3.10; CI 95%: 1.26-7.65; p value: 0.011).
Patients with overweight and obesity (BMI ≥25 kg/m2) are 2.08 times more likely to develop MSAP and SAP in comparison to those who got a BMI <25 (OR: 2.08; CI 95%:1.02-4.21; valor p: 0.040).
Regarding patients who developed MSAP and SAP, 74.1% of them showed pleural effusion, with an OR of 7.78 and a p value <0.001. When it comes to patients with hematocrit >40%, they were 4.17 times more likely to develop MSAP and SAP, in contrast to those who got hematocrit <40% (OR: 4.17; CI 95%: 2.07-8.39; p value: <0.001).
In the matter of Apache score of ≥8 marks, we noted that patients were 7.88 times more likely to show disease severity in comparison with those who got a score of <8 (OR: 7.88; CI 95%: 3.77-16.45; p value:<0,001). The variable with which there was not statistically non-significant association was glycaemia’s ≥200 mg/dl.
| Variables | Adjusted OR | CI 95% | P value |
| Age | 0,735 | (0,202-2,679) | 0,641 |
| BMI | 7,153 | (2,150-23,801) | 0,001 |
| Pleural effusion | 17,682 | (5,745-54,418) | 0,001 |
| Hematocrit | 4,220 | (1,593-11,180) | 0,004 |
| APACHE | 25,064 | (7,341-85,576) | <0,001 |
For the multivariate analysis displayed on table 3, we carried out a binary logistic regression analysis with the results obtained in the bivariate analysis, considering statistically significant variables.
The severity prognostic factors in patients with acute pancreatitis during the period from June 2016 until June 2018 were BMI ≥25 kg/m2 (p=0.001), pleural effusion (p=<0.001), hematocrit (p=<0.001) and apache ≥8 points (p=<0.001), all these factors with statistically significant values.
DISCUSSION
In this research, regarding epidemiological characteristics in patients with acute pancreatitis, we found that 33.3% of patients developed moderately severe acute pancreatitis (MSAP) or severe (SAP). Ocampo et al found similar studies with mild AP of 83.6% and severe AP of 16,4%(2) in 2015.; Likewise in 2012, Enrique Madaria mentions in his study that 39.1% developed severe AP(29). These numbers cannot be compared with Molina’s research in 2013, which concluded that 82.4% corresponded to severe acute pancreatitis.(30).
Regarding the relationship between severity and sex, Molina obtained that female (53%) prevailed in terms of acute pancreatitis, in general. Nonetheless, concerning severe acute pancreatitis, it was male sex (53.6%)(30) who prevailed. In our research, we found that 55.6% of MSAP and SAP were from male; while female sex prevailed regarding mild AP with 91.7%.
In relation to the etiology of acute pancreatitis, 83.3% were of biliary origin, 11.7% alcoholic and 4.9% had other causes. Gompertz et al noted that the most frequent etiology of AP was biliary, reaching 80-100% of causes in some hospitals in Ecuador and Peru, and 45-60% in Chile, Argentina and Brazil(1). Alcohol consumption was an etiologic factor in 10-20%, with a similar number of cases considered idiopathic(1); Ocampo et al name a similar result with 88.2% of biliary etiology as the main cause of acute pancreatitis(2).
Concerning the relationship between disease severity and etiology, we obtained that 64.8% of MSAP and SAP were of biliary etiology. Amongst mild AP, it prevailed the same etiology. These findings agree with Molina, who found that the main cause of acute pancreatitis, in both mild and severe, was a biliary process with a proportion over 80%.(30)
In a 2011 research carried out by Chavarría et al, at National Hospital Cayetano Heredia, they found that APACHE II score with a cut-off point of 8 presented 9.02 times more likelihood to show disease severity with a p value under 0.01, in contrast to the group who showed the mild form.(9). This agrees with our study’s findings, where we noted that an apache of ≥8 points apache represents 7.88 times the likelihood to develop severe acute pancreatitis, in comparison with those who got an apache of <8 points (OR: 7.88; CI 95%: 3.77-16.45; p value:<0.001). Jin et al, in 2017, proved that an APACHE II score of ≥ 8 was a risk factor for developing moderately severe AP or severe AP with an OR of 29.096 and a p value of <0.00133. Furthermore, we carried out the multivariate analysis of statistically significant variables. There we could note related results to our research with an OR of 25.064 and a p value of <0.001. Thus, proving to be a useful predictor for discerning between both groups in our environment.
Pacheco et al, in 2009, reported that acute pancreatitis severity was influenced by age (OR: 1.02; IC 95%: 1.01–1.04, p value: 0.001)(15). Our research does not agree, however, with the previous result. We carried out a multivariate analysis to every bivariate analysis’ statistically significant variable, but we did not found statistical significance in age >60 years old as a severity prognostic factor (OR: 0.735, CI 95%: 0.202-2.679; p value: 0.641). In a research by Roulin et al in 2018, we found similar results. There was no difference regarding clinical and radiological severity of acute pancreatitis between elderly and young people (p value: 0.210).(19).
In our research, a BMI ≥25 kg/m2, was statistically significant (OR: 2.08; CI 95%:1.02-4.21; p value: 0.040). Many published studies support this argument, since obesity is one of the most significant severity negative prognostic factors and increases both risk of local and systemic complications. According to Fei Y et al in 2017, univariate analysis confirmed that BMI Is significantly related to severity of AP with an OR of 0.917; IC 95%: 0.682-1.733, valor p: 0.011(20). Likewise, in a study published at National Hospital Daniel Alcides Carrión by Guzmán in 2012, 14 out of 16 patients with severe pancreatitis got a BMI > 25. (p = 0.03; OR = 4.39)(25). The relationship between obesity and development of severe acute pancreatitis is due to the fact that obese patients have a chronic proinflammatory state, which may predispose them to a major inflammatory response if they develop acute pancreatitis. The hypothesis that supports this evidence comes from two studies that show an increase in both protein C and proinflammatory cytokines levels (IL-1b, IL-6 e IL8) in obese patients with acute pancreatitis in comparison with non-obese patients.(25)
Regarding blood glucose level, we did not found any statistical significance in our study (OR: 2.50; CI95%: 0.95-6.58; p value: 0.058), even though a study by Speranskaya in 2015 reports that blood glucose >200 after being admitted to the hospital is related with severity degree of pancreatitis (p < 0.001).(21). More studies are need in order to reaffirm these findings and to observe if a better glycaemia control while being admitted to the hospital influences in the hospital evolution of pancreatitis.
Hematocrit has been described in a number of studies as a possible severity marker in acute pancreatitis. Pathophysiologically, in severe cases it exists a redistribution of intravascular fluid towards a third space as a consequence of inflammatory process due to the initiation of inflammatory cascade, which joins a local process after an increase of pancreatic enzymes’ release. Thus, detection of this reduction in the intravascular volume could be related to disease severity. Chavarría et al (2001) state in their research that hematocrit average value in the group labeled as mild was 38.40%, whereas in the group of severe patients this average was 39.78% with p value: 0.182. Thus, it was a non-significant difference(9). However, in our study we obtained that patients who got hematocrit >40% were 4.17 times more likely to develop MSAP and SAP, unlike those who got hematocrit <40% (OR: 4.17; CI 95%: 2.07-8.39; p value: <0.001). Likewise, Sánchez in 2015 proved hematocrit to be a great predictor of acute pancreatitis severity with p value of 0.012.(34).
Presence of pleural effusion, an easy-to-prove mark, has been reported as a proper prognostic factor in various scientific papers. Nevertheless, in these papers presence of pleural effusion was researched through different radiological methods and within heterogeneous population with different etiologies in their pancreatitis. Also, in those papers, there is no comparison between predictive accuracy of presence of pleural effusion and prognostic systems of traditional multi-criteria. In our study, we obtained the following as a result of bivariate analysis: OR of 7.78 with a CI 95% between 3.70-16.35 y and p value of <0.001. This result is similar to the study published by Ocampo et al (2008), where evaluated pleural effusion through echography presented higher values of predictive accuracy in predicting systemic complications (OR: 6.3 CI95%: 2.85-14)(23). Further, León C. (2015) found in his research work that 100% of patients with severe pancreatitis presented pleural effusion(35).
CONCLUSION
In our study we established that pleural effusion is more frequent in patients with severe acute pancreatitis and together with the APACHE scale they were significantly associated, being the best predictors of disease severity.
Authorship contributions: The authors participated in the genesis of the idea, project design, collection and interpretation of data, analysis of results and preparation of the manuscript of the present work of investigation.
Financing: self-financed.
Conflict of interest:Los autores no presentan ningún conflicto de intereses relevante en este artículo.
Received: 29 de Octubre 2019
Approved: 13 de Diciembre 2019
Correspondent author: Hellen Jamanca Milian
Address: Av. Huayna Cápac 908- Comas - Lima - Perú.
Telephone: 986958290
E-mail: hellen25_2@hotmail.com
BIBLIOGRAPHIC REFERENCES
1. Macarena Gompertz, Ivone Lara, Lara Fernández, Juan Pablo Miranda, Carla Mancilla, Guillermo Watkins, et al. Mortalidad de la pancreatitis aguda: experiencia de 20 años en el Hospital Clínico Universidad de Chile. Rev Med Chile 2013; 141: 562-567.
2. Carlos Ocampo, Gustavo Kohan, Fabio Leiro, Sandra Basso, Silvia Gutiérrez, Lorena Perna, et al. Diagnóstico y tratamiento de la pancreatitis aguda en la Argentina. Resultados de un estudio prospectivo en 23 centros. Acta Gastroenterol Latinoam 2015;45:295-302
3. Julio Alberto Nieto, Samuel Rodriguez. Manejo de la pancreatitis aguda: guía de práctica clínica basada en la mejor información disponible. Rev Colomb Cir. 2010; 25:76-96.
4. Donaldo Bustamante Durón, Ana García Laínez, Wenndy Umanzor García, Loany Leiva Rubio, Alejandra Barrientos Rosales, et al. Pancreatitis Aguda: Evidencia Actual. Archivos de medicina. 2018; 14(1,4): 1-10.
5. Marco Antonio Valdivieso-Herrera, Luis Oswaldo Vargas-Ruiz, Alejandra Rosa Arana- Chiang, Alejandro Piscoya. Situación epidemiológica de la pancreatitis aguda en Latinoamérica y alcances sobre el diagnóstico. Acta Gastroenterol Latinoam 2016;46:102- 103.
6. Jorge Huerta-Mercado. Tratamiento médico de la pancreatitis aguda. Rev Med Hered. 2013; 24:231-236.
7. Anaïs Acevedo Tizón, Javier Targarona Modena, Germán Málaga Rodríguez, Luis Barreda Cevasco. Identificando a la Pancreatitis aguda severa. Rev. Gastroenterol. Perú; 2011; 31-3: 236-240.
8. Y. Surco, J. Huerta Mercado, J. Pinto, A. Piscoya, R. De Los Ríos, et al. Predicción Precoz de Severidad en Pancreatitis Aguda. Rev. Gastroenterol. Perú; 2012; 32-3: 241-250.
9. Carlos Miguel Chavarría Herbozo, Jorge Luis Espinoza Ríos, David Alberto Kawano Kobashigawa, Yolanda Surco, Eduard Bravo, et al. Hemoconcentración, Apache II y Ranson como Predictores Tempranos de Severidad en Pacientes con Diagnóstico de Pancreatitis Aguda en un Hospital de Lima – Perú. Rev. Gastroenterol. Perú; 2011; 31-1: 26-31.
10. Martín Gómez Zuleta, Xiomara Ruiz Lobo, William Otero Regino. Nueva escala simple y rápida para predecir la severidad de pancreatitis aguda. Rev Col Gastroenterol [online]. 2010, vol.25, n.2, pp.118-127.
11. Alina Breijo Puentes, Juan Andrés Prieto Hernández. Pancreatitis aguda. Artículo de revision. Intramed journal. 2014; 3(2): 1-14.
12. Ocampo Carlos, Zandalazini Hugo, Pekolj Juan, Kohan Gustavo. Guía práctica para el manejo de la pancreatitis aguda. Club del páncreas república Argentina.2011. Disponible en: www.pancreasclub.com.ar.
13. Pando E., Alberti P., Hidalgo J., Vidal L., Dopazo C., et al. The role of extra-pancreatic infections in the prediction of severity and local complications in acute pancreatitis. July 2018; 18(5): 486-493.
14. Premkumar R., Anthony R.J, Maxim S., Jhon A. Windsor. The clinical relevance of obesity in acute pancreatitis: Targeted systematic reviews. January-February 2015; 15(1):25-33.
15. G.Pacheco, I.Pascual, J.Lizarraga, J.Tosca, A.Ga-Bolós, et al. Edad y comorbilidad como factores pronósticos en pancreatitis aguda biliar. Gastroenterología y hepatología. Marzo 2009; 32 (3):238.
16. Iria Alfonso Salabert, Idalmis Salabert Tortolo, José Claro Alfonso Prince, María del Carmen Álvarez Escobar, Arnella Torres Álvarez, et al. Factores de riesgo para pancreatitis aguda en el Hospital Comandante Faustino Pérez de Matanzas. Noviembre-diciembre 2017; 39(6):1259-1267.
17. Samer Sawalhi, Hamdi Al-Maramhy, Abdelrahman I, Salah Eldin Geib Allah, Salman Al-Jubori. Does the Presence of Obesity and/or Metabolic Syndrome Affect the Course of Acute Pancreatitis? May 2014; 43(4):565-570.
18. Su Mei CHEN, Guang Su XIONG & Shu Ming WU. Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. Journal of Digestive Diseases 2012; 13; 244–251.
19. Didier Roulin, Raphaël Girardet, Rafael Duran, Steven Hajdu, Alban Denys, et al. Outcome of elderly patients after acute biliary pancreatitis. BioScience Trends. 2018; 12(1):54-59.
20. Fei Y, Gao K, Tu J, Wang W, Zong G, & Li W. Predicting and evaluation the severity in acute pancreatitis using a new modeling built on body mass index and intra-abdominal pressure. Am J Surg [Internet]. 2017 Jun [citado 2017 Sep 22]; Disponible en: http:// linkinghub.elsevier.com/retrieve/pii/S0002961017304312
21. A. Speranskaya, J. Nicolau, P. Sanchis, A. Gómez, L. Ayala, R. Fortuny y L. Masmiquel. Pancreatitis aguda y diabetes: Características Clínico-epidemiológicas y factores condicionantes de su evolución clínica. Avances en diabetología 2015;31(Espec Congr):59
22. Zhang, J. , Shahbaz, M. , Fang, R. , Liang, B. , Gao, C. , Gao, H. , Ijaz, M. , Peng, C. , Wang, B. , Niu, Z. and Niu, J. (2014), Comparison of the BISAP scores for predicting the severity of acute pancreatitis in Chinese patients according to the latest Atlanta classification. J Hepatobiliary Pancreat Sci, 21: 689-694.
23. Ocampo, Carlos & Silva, Walter & Zandalazini, Hugo & Kohan, Gustavo & Sanchez, Nicolas & Oría, Alejandro. (2008). Superioridad del derrame pleural sobre los criterios múltiples en el pronóstico de la pancreatitis aguda biliar. Acta Gastroenterol Latinoam 2008;38:34-42
24. Marcos Kutz Leoz, Rebeca Irisarri Garde, Juan José Vila Costas, Ana Martínez Echeverría, Inmaculada Elizalde Apestegui, Marta Basterra Ederra, Marta Gómez Alonso, José Manuel Zozaya Urmeneta. (2012). Derrame pleural secundario a fístula pancreático-pleural pospancreatitis aguda. Gastroenterol Hepatol 2012;35:70-3.
25. Guzmán Calderon Edson, Montes Teves Pedro, Monge Salgado Eduardo. BISAP-O: obesidad incluida en el score BISAP para mejorar la predicción de severidad en pancreatitis aguda. Rev. gastroenterol. Perú. 2012 Jul; 32( 3 ): 251-256.
26. Tumbaco, E. Pancreatitis aguda. Factores de riesgo y complicaciones en pacientes entre 20 a 40 años. (Tesis de titulación). Universidad de Guayaquil, Facultad de Ciencias Médicas. Ecuador, 2016
27. Pérez Campos Agnetha, Bravo Paredes Eduar, Prochazka Zarate Ricardo, Bussalleu Alejandro, Pinto Valdivia José, Valenzuela Granados Vannessa. BISAP-O y APACHE-O: utilidad en la predicción de severidad en la pancreatitis aguda según la clasificación modificada de Atlanta. Rev. Gastroenterol Perú [online]. 2015; 35( 1 ): 15-24.
28. J.A. González, R. Castaneda, M.A. Martínez, D. García, A.R. Flores, H.J. Maldonado, et al. Características clínicas de la pancreatitis aguda en México. Revista de Gastroenterología de México. 2012;77(4):167-173.
29. Enrique de-Madaria. Últimos avances en pancreatitis aguda. Gastroenterol Hepatol. 2013;36(Supl 2):98-102}
30. Molina, J. Características clínicas, epidemiológicas y terapéuticas de la pancreatitis aguda grave. (Tesis de titulación). Universidad Nacional de Trujillo, Facultad de Medicina. Trujillo-Perú, 2013.
31. E. Maraví-Pomaa, E. Patchen Dellinger, C.E. Forsmarkc, P. Layer, P. Lévy, T. Shimosegawa. Clasificación Internacional y Multidisciplinaria de la Pancreatitis Aguda: Edición espanola 2013. Med Intensiva. 2014;38(4):211---217.
32. González-Garza F, García-Zermeño K, Álvarez-López F. Validación de las escalas BISAP, APACHE II y RANSON para predecir falla orgánica y complicaciones en pancreatitis aguda. Rev Médica MD. 2013;4.5(2):66-72.
33. Jin Z, Xu L, Wang X, & Yang D. Risk Factors for Worsening of Acute Pancreatitis in Patients Admitted with Mild Acute Pancreatitis. Med Sci Monit Int Med J Exp Clin Res. 2017 Feb; 23: 1026-32.
34. Sanchez C. Valor de la hemoconcentración como predictor temprano de severidad en pancreatitis aguda, en pacientes ingresados en el Hospital México durante el periodo de enero del 2003 a diciembre del 2012. (Tesis para especialización). Universidad de Costa Rica, Sistema de estudios de posgrado. Costa Rica, 2015.
35. León C. Derrame pleural como predictor de severidad en pancreatitis aguda.(Tesis para especialización). Universidad Mayor de San Marcos, Facultad de Medicina Humana. Lima- Perú, 2013.
36. Sánchez Alejandra Consuelo, García Aranda José Alberto. Pancreatitis aguda. Bol. Med. Hosp. Infant. Mex. 2012. 69(1):3-10.
37. Lipovestky F, Tonulli C, Ramos A, Cueto G, Guimaraens P, Reina R, et al. Pancreatitis aguda. Su manejo en cuidados intensivos. MEDICINA INTENSIVA. 2016; 33(1):47-59
38. Orellana, P. Pancreatitis aguda: revisión de las nuevas guías del 2013. Medicina Legal de Costa Rica - Edición Virtual. 2014: 31(1): 1409-1415
39. Hernández, J. Pancreatitis aguda. Revista de Gastroenterología de México. 2013;78(1): 40-41
40. González J, Luque E, Cedillo E, Juárez M, González D, Moreno C, et al. Guía práctica clínica. Pancreatitis Aguda. Asociación mexicana de cirugía general A. C. 2014
41. De la Cruz Vargas JA, Correa Lopez LE, Alatrista Gutierrez de Bambaren M del S. Sanchez Carlessi HH, Luna Muñoz C, Loo Valverde M, et al. Promoviendo la investigación en estudiantes de Medicina y elevando la producción científica en las universidades: experiencia del Curso Taller de Titulación por Tesis. Educ Médica [Internet]. 2 de agosto de 2018 [citado 16 de enero de 2019]. Disponible en: http://www.sciencedirect.com/science/ article/pii/S1575181318302122
